Thursday 23rd September 2021
|Text too small?|
Cancer diagnostics company, Pacific Edge Limited is pleased to announce that it has been admitted to the official list of the Australian Securities Exchange (ASX) as a foreign exempt listing and is conducting an equity raise consisting of a placement of NZ$60 million (A$58.1 million) with a Retail Offer of up to NZ$20 million (A$19.4 million) to eligible investors to capitalise on recent commercial milestones and to accelerate the execution of its growth strategy in markets of scale.
Pacific Edge Admitted as Foreign Exempt Listing on ASX
The ASX has approved Pacific Edge’s application for a foreign exempt listing on the ASX and admitted the Company to the official list of ASX on the evening of 22 September 2021. Trading of Pacific Edge’s shares on ASX is expected to commence at 11:00am (AEST) / 2:00pm (NZDT) on Monday 27 September 2021, enabling shareholders to trade their Pacific Edge shares on the NZX or ASX.
Pacific Edge has been allocated the ASX ticker code of "PEB". To trade on either exchange, shares will need to be registered on the share register for the particular jurisdiction. Shareholders wishing to move their shares to the ASX or NZX register should contact either their share broker or Pacific Edge's share registry, Link Market Services Limited, either by calling 09 375 5998 or email email@example.com. Pacific Edge will proudly remain a New Zealand company and continue its primary listing on the NZX.
Capital Raising to Accelerate Growth Opportunities
Pacific Edge is conducting an equity raise to capitalise on recent commercial milestones and execute and accelerate its growth strategy in markets of scale.
Details of the Placement
Pacific Edge intends to undertake a Placement of new shares to raise around NZ$60 million (A$58.1 million). The institutional bookbuild and Placement will occur while Pacific Edge is in trading halt, with participants expected to include a range of institutional and wholesale investors from New Zealand, Australia and internationally. A trading halt has been granted by NZX prior to the market opening today.
Bell Potter Securities Limited, Forsyth Barr Limited and Jarden Securities Limited are the Joint Lead Managers for the Placement.
Details of the Retail Offer
Following completion of the Placement, Pacific Edge intends to offer Eligible Shareholders in New Zealand the opportunity to participate in a Retail Offer, to raise up to a further NZ$20 million (A$19.4 million). Each Eligible Shareholder will be entitled to subscribe for up to NZ$50,000 of new shares under the Retail Offer. Shares will be offered at the lower of the price paid for shares under the placement and the volume weighted average price of Pacific Edge's shares on the NZX over the 5-day trading period before the closing date of the retail offer (being 13 October 2021, unless extended). The full terms of the Retail Offer will be contained in the Retail Offer document which will be distributed to all Eligible Shareholders in due course.
Pacific Edge concludes that the Retail Offer will cater for a high majority of the Company’s non institutional shareholders, enabling them to participate and potentially increase their relative percentage holdings in Pacific Edge.
Please see the links below for details
No comments yet
NZME celebrates significant digital subscription milestone
GSH - Acquisition of Viaduct venue
DGL - Delisting from the Main Board of NZX Limited
KPG Annual Meeting 2022 presentation and address
NZL - Completion of Retail Bookbuild
ArborGen Announces Board Change
Oceania announces $500m sustainability-linked loan
MFB - Nomination of Cecilia Robinson
29th June 2022 Morning Report
GSH Appointment of new Chairman